(8Z,11Z,14Z)-8,11,14-Icosatrien-5-ynoic acid
(8Z,11Z,14Z)-8,11,14-Icosatrien-5-ynoic acid structure
|
Common Name | (8Z,11Z,14Z)-8,11,14-Icosatrien-5-ynoic acid | ||
|---|---|---|---|---|
| CAS Number | 58688-54-3 | Molecular Weight | 302.451 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 444.7±45.0 °C at 760 mmHg | |
| Molecular Formula | C20H30O2 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 212.2±23.4 °C | |
| Symbol |
GHS02, GHS07 |
Signal Word | Danger | |
Use of (8Z,11Z,14Z)-8,11,14-Icosatrien-5-ynoic acid5,6-dehydro Arachidonic acid is an analog of arachidonic acid with an acetylene in the 5,6 position. |
| Name | 5,6-Dehydroarachidonic acid |
|---|---|
| Synonym | More Synonyms |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 444.7±45.0 °C at 760 mmHg |
| Molecular Formula | C20H30O2 |
| Molecular Weight | 302.451 |
| Flash Point | 212.2±23.4 °C |
| Exact Mass | 302.224579 |
| PSA | 37.30000 |
| LogP | 6.63 |
| Vapour Pressure | 0.0±2.3 mmHg at 25°C |
| Index of Refraction | 1.507 |
| Symbol |
GHS02, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H319 |
| Precautionary Statements | P210-P280-P305 + P351 + P338-P337 + P313-P403 + P235 |
| Risk Phrases | 11-16 |
| Safety Phrases | 16 |
| RIDADR | UN 1170 3/PG 2 |
CAS#:77297-91-7
CAS#:42017-07-2
CAS#:82645-30-5
CAS#:82645-32-7
CAS#:82645-33-8
CAS#:70219-59-9|
Strong suppression by mononuclear leukocytes from human newborns on maternal leukocytes: mediation by prostaglandins.
Clin. Immunol. Immunopathol. 23(3) , 606-15, (1982)
|
|
|
[Synthesis of (8Z,11Z,14Z)-eicosatrien-5-ynoic (5,6-dehydroarachidonic) acid and its transformation into [5,6-3H]arachidonic acid and [5,6-3H]prostaglandins E2 and F2 alpha].
Bioorg. Khim. 13(3) , 415-9, (1987) 8Z,11Z,14Z-Eicosatriene-5-ynoic acid and its tritium-labelled analogue, [5,6-3H]arachidonic acid, have been synthesized on the basis of acetylenic compounds. [5,6-3H]Arachidonic acid has been used as ... |
|
|
An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
J. Immunol. 133(2) , 938-45, (1984) The quantitative relationships between the secretion of a granule-associated mediator, beta-hexosaminidase, and the oxidative metabolism of arachidonic acid by the 5-lipoxygenase pathway were analyzed... |
| (8Z,11Z,14Z)-Icosa-8,11,14-trien-5-ynoic acid |
| (8Z,11Z,14Z)-8,11,14-Icosatrien-5-ynoic acid |
| 5,6-dehydroarachidonic acid |
| 8,11,14-Eicosatrien-5-ynoic acid, (8Z,11Z,14Z)- |